Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Assessment of programmed cell death-ligand 1 (PD-L1) expression by immunohistochemistry (IHC) is the definite diagnostic test to guide treatment for patients with advanced-stage non-small cell lung cancer. Intratumoral heterogeneity and discrepancy of PD-L1 expression between primary and metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Moutafi, Myrto K, Tao, Weiwei, Huang, Richard, Haberberger, James, Alexander, Brian, Ramkissoon, Shakti, Ross, Jeffrey S, Syrigos, Konstantinos, Wei, Wei, Pusztai, Lajos, Rimm, David L, Vathiotis, Ioannis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039214/
https://www.ncbi.nlm.nih.gov/pubmed/33833050
http://dx.doi.org/10.1136/jitc-2020-002230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039214/
https://www.ncbi.nlm.nih.gov/pubmed/33833050
http://dx.doi.org/10.1136/jitc-2020-002230

Ejemplares similares